CP1150 Sound Processor Speech Perception Compared With the Next Generation of Signal Processing Technology
NCT ID: NCT05286385
Last Updated: 2025-02-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2022-05-30
2022-06-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acceptance and Performance of the CP1170 Sound Processor in Experienced Adult Cochlear Implant Recipients
NCT05619575
New Algorithms to Signal Processing for Speech Enhancement in Adult Cochlear Implant Recipients.
NCT06100393
Investigating Stimulation Parameter and Electrode Mode Changes on Speech Perception in Experienced Adult Cochlear Implant Recipients
NCT06298396
Subject´s Preference Regarding Hearing Performance and Functionality Using a New Sound Processor
NCT03848910
Sound Processing Innovations in Adult and Paediatric Cochlear Implant Recipients.
NCT05476328
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test Order 1
CP1150, then CP1150 NF, then CP1110, then CP1150 + FF
CP1150 Sound Processor
Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor
CP1150 NF
Speech perception tests whilst the subject is fitted with the CP1150 modified firmware (the addition of notch filters at 978Hz, 1956Hz, 2934Hz, 3912Hz).
CP1150 + FF
Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor with ForwardFocus.
CP1110
Speech perception tests whilst the subject is fitted with the CP1110 Sound Processor.
Test Order 2
CP1150 NF, then CP1150 + FF, then CP1150, then CP1110
CP1150 Sound Processor
Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor
CP1150 NF
Speech perception tests whilst the subject is fitted with the CP1150 modified firmware (the addition of notch filters at 978Hz, 1956Hz, 2934Hz, 3912Hz).
CP1150 + FF
Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor with ForwardFocus.
CP1110
Speech perception tests whilst the subject is fitted with the CP1110 Sound Processor.
Test Order 3
CP1150 + FF, then CP1110, then CP1150 NF, then CP1150
CP1150 Sound Processor
Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor
CP1150 NF
Speech perception tests whilst the subject is fitted with the CP1150 modified firmware (the addition of notch filters at 978Hz, 1956Hz, 2934Hz, 3912Hz).
CP1150 + FF
Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor with ForwardFocus.
CP1110
Speech perception tests whilst the subject is fitted with the CP1110 Sound Processor.
Test Order 4
CP1110, thenCP1150, then CP1150 + FF, then CP1150 NF
CP1150 Sound Processor
Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor
CP1150 NF
Speech perception tests whilst the subject is fitted with the CP1150 modified firmware (the addition of notch filters at 978Hz, 1956Hz, 2934Hz, 3912Hz).
CP1150 + FF
Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor with ForwardFocus.
CP1110
Speech perception tests whilst the subject is fitted with the CP1110 Sound Processor.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CP1150 Sound Processor
Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor
CP1150 NF
Speech perception tests whilst the subject is fitted with the CP1150 modified firmware (the addition of notch filters at 978Hz, 1956Hz, 2934Hz, 3912Hz).
CP1150 + FF
Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor with ForwardFocus.
CP1110
Speech perception tests whilst the subject is fitted with the CP1110 Sound Processor.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Post lingually deafened
3. Implanted with the CI600 Series, CI500 Series or Freedom Series
4. At least 6 months experience with a cochlear implant.
5. At least 3 months experience with a CP910/920, CP950, CP1150, or CP1000 Sound Processor
6. MAP Total Stimulation Rate of 7.2kHz or greater
7. Able to score 30% or more with CI alone on a monosyllabic words in quiet test
8. Willingness to participate in and to comply with all requirements of the protocol
9. Fluent speaker in English as determined by the investigator
10. Willing and able to provide written informed consent
Exclusion Criteria
2. Implant location that would result in undesirable hearing performance or discomfort with an off-the-ear sound processor, as determined by the investigator.
3. Unable or unwilling to comply with the requirements of the clinical investigation, as determined by the Investigator.
4. Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling.
5. Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation.
6. Currently participating or participated in another interventional clinical study/trial in the past 30 days unless (if less than 30 days) the prior investigation was Cochlear sponsored and determined by the investigator to not impact clinical findings of this investigation.
7. Implanted with other active implantable medical devices (e.g. pacemaker, defibrillator).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cochlear
INDUSTRY
Avania
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cochlear Sydney
Macquarie Park, New South Wales, Australia
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLTD5818
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.